Deutsche Bank’s Ionis Pharmaceuticals IONS Stock Holding History

Deutsche Bank’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-780	Closed	-$48K	–	5544
2014 Q4	$48K	Buy	780 +450	+136%	+$22.2K	﹤0.01%	5147
2014 Q3	$12K	Sell	330 -350	-51%	-$12.4K	﹤0.01%	5346
2014 Q2	$23K	Buy	+680	New	+$21.4K	﹤0.01%	5267
2014 Q1	–	Sell	-1,500	Closed	-$21K	–	5687
2013 Q4	$21K	Hold	1,500	–	–	﹤0.01%	4713
2013 Q3	$19K	Buy	1,500 +1,250	+500%	+$37.3K	﹤0.01%	4906
2013 Q2	$2K	Buy	+250	New	+$5.32K	﹤0.01%	5163

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank's IONS Position: Q1 2026 in Review

Deutsche Bank increased its Ionis Pharmaceuticals (IONS) stake by 7% in Q1 2026, buying an estimated $825K and bringing the position to 159,891 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #999.

Deutsche Bank first reported a position in IONS in Q2 2013 and has held it in 52 quarters since. The position peaked at $68M in Q3 2017. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

Deutsche Bank held 159,891 shares of Ionis Pharmaceuticals worth $12M as of Q1 2026.
Deutsche Bank bought 10,448 Ionis Pharmaceuticals shares in Q1 2026, an estimated $825K.
Ionis Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #999 holding.
Deutsche Bank first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
Deutsche Bank's Ionis Pharmaceuticals position peaked at $68M in Q3 2017.
493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.